Market Cap 60.57B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 18.73
Forward PE 17.55
Profit Margin 0.48%
Debt to Equity Ratio 3.45
Volume 800,095
Avg Vol 1,503,854
Day's Range N/A - N/A
Shares Out 194.56M
Stochastic %K 41%
Beta 0.58
Analysts Strong Sell
Price Target $352.85

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
27R
27R Aug. 4 at 3:29 PM
$COR Buckle up — earnings before the open tomorrow.
0 · Reply
JustinSilva985
JustinSilva985 Aug. 3 at 3:09 PM
$COR $DAL $BKR $O $F Cencora leads pharmaceutical distribution, Delta Air Lines benefits from travel demand, Baker Hughes expands energy technology, Realty Income generates dependable dividends, and Ford advances its EV and truck strategy.
0 · Reply
DonaldTillman163
DonaldTillman163 Aug. 3 at 2:43 PM
$COR $DAL $BKR $O $F Cencora leads pharmaceutical distribution, Delta Air Lines benefits from travel demand, Baker Hughes expands energy technology, Realty Income generates dependable dividends, and Ford advances its EV and truck strategy.
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 28 at 5:27 PM
$COR $ABC $HUM $OTLK https://www.nbcnews.com/id/wbna14785668
0 · Reply
Texastradinggirl
Texastradinggirl Jul. 27 at 8:02 PM
$OTLK Thoughts on this please..... Cencoran's Chairman of the Board placed an insider trade in June. (his own money) $COR He seems to be involved in taking this product to market. What do you think may be going on?
0 · Reply
CrazyChief
CrazyChief Jul. 25 at 2:54 PM
$OTLK Definitely know what you own!!! $COR
0 · Reply
CrazyChief
CrazyChief Jul. 24 at 11:43 PM
$OTLK Having the US FDA approval is Huge, sit back and enjoy the ride!! $COR is involved, many possibilities in our future!!
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 24 at 10:26 PM
$OTLK Congrats on #OTLK’s 1st FDA APPROVAL DAY! $ABC $COR $PILL In the USA, do you predict after initial orders, that reordering is frequently:
0 · Reply
CrazyChief
CrazyChief Jul. 24 at 7:25 PM
$OTLK $COR BIG THINGS WILL HAPPEN
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 24 at 6:32 PM
0 · Reply
Latest News on COR
Cencora price target raised to $310 from $285 at BofA

2026-07-21T12:50:39.000Z - 14 days ago

Cencora price target raised to $310 from $285 at BofA


Cencora price target raised to $285 from $280 at BofA

2026-06-24T11:00:13.000Z - 5 weeks ago

Cencora price target raised to $285 from $280 at BofA

CI MCK


Suncrete, Inc. Completes Arkansas Acquisition

Jun 15, 2026, 4:15 PM EDT - 7 weeks ago

Suncrete, Inc. Completes Arkansas Acquisition

RMIX


Cencora price target lowered to $350 from $425 at Barclays

2026-06-10T09:16:02.000Z - 7 weeks ago

Cencora price target lowered to $350 from $425 at Barclays


Cencora appoints Eva Boratto as CFO

2026-05-27T11:38:00.000Z - 2 months ago

Cencora appoints Eva Boratto as CFO


Cencora still sees long-term adjusted EPS growth of 10%-14%

2026-05-27T11:34:42.000Z - 2 months ago

Cencora still sees long-term adjusted EPS growth of 10%-14%


Cencora Announces Updated Fiscal Year 2026 Financial Outlook

May 21, 2026, 4:30 PM EDT - 2 months ago

Cencora Announces Updated Fiscal Year 2026 Financial Outlook


Cencora price target lowered to $339 from $420 at Baird

2026-05-07T16:03:22.000Z - 3 months ago

Cencora price target lowered to $339 from $420 at Baird


Cencora price target lowered to $300 from $360 at Evercore ISI

2026-05-07T13:57:35.000Z - 3 months ago

Cencora price target lowered to $300 from $360 at Evercore ISI


Cencora price target raised to $412 from $410 at UBS

2026-05-07T13:27:00.000Z - 3 months ago

Cencora price target raised to $412 from $410 at UBS


Cencora price target lowered to $355 from $405 at Citi

2026-05-07T11:17:45.000Z - 3 months ago

Cencora price target lowered to $355 from $405 at Citi


Cencora reports Q2 adjusted EPS $4.75, consensus $4.73

2026-05-07T09:39:48.000Z - 3 months ago

Cencora reports Q2 adjusted EPS $4.75, consensus $4.73


Cencora Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Cencora Earnings Call Transcript: Q2 2026


Cencora Earnings release: Q2 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Cencora Earnings release: Q2 2026


Cencora Slides: Q2 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Cencora Slides: Q2 2026


Cencora Quarterly report: Q2 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Cencora Quarterly report: Q2 2026


Cencora raises annual profit forecast despite quarterly miss

May 6, 2026, 7:41 AM EDT - 3 months ago

Cencora raises annual profit forecast despite quarterly miss


Cencora Reports Fiscal 2026 Second Quarter Results

May 6, 2026, 6:30 AM EDT - 3 months ago

Cencora Reports Fiscal 2026 Second Quarter Results


Cencora initiated with a Market Perform at William Blair

2026-04-28T10:11:54.000Z - 3 months ago

Cencora initiated with a Market Perform at William Blair


Cencora price target lowered to $360 from $420 at Evercore ISI

2026-04-08T13:22:35.000Z - 4 months ago

Cencora price target lowered to $360 from $420 at Evercore ISI


Cencora Announces Financial Leadership Transition

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Cencora Announces Financial Leadership Transition


Cencora Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 2:20 PM EDT - 5 months ago

Cencora Transcript: Leerink Global Healthcare Conference 2026


Cencora Transcript: AGM 2026

Mar 5, 2026, 3:30 PM EST - 5 months ago

Cencora Transcript: AGM 2026


Covetrus and MWI Animal Health to Merge

Feb 18, 2026, 7:00 AM EST - 5 months ago

Covetrus and MWI Animal Health to Merge


Cencora Closes $3.0 Billion Senior Notes Offering

Feb 13, 2026, 4:15 PM EST - 6 months ago

Cencora Closes $3.0 Billion Senior Notes Offering


Cencora Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 6 months ago

Cencora Earnings Call Transcript: Q1 2026


Cencora Quarterly report: Q1 2026

Feb 4, 2026, 8:30 AM EST - 6 months ago

Cencora Quarterly report: Q1 2026


Cencora Earnings release: Q1 2026

Feb 4, 2026, 8:30 AM EST - 6 months ago

Cencora Earnings release: Q1 2026


Cencora Slides: Q1 2026

Feb 4, 2026, 8:30 AM EST - 6 months ago

Cencora Slides: Q1 2026


Cencora Reports Fiscal 2026 First Quarter Results

Feb 4, 2026, 6:30 AM EST - 6 months ago

Cencora Reports Fiscal 2026 First Quarter Results


Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 6 months ago

Cencora Elects Ellen Cooper to Its Board of Directors


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 6 months ago

Cencora Proxy statement: Proxy Filing


Cencora Proxy statement: Proxy Filing

Jan 22, 2026, 7:00 AM EST - 6 months ago

Cencora Proxy statement: Proxy Filing


Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 7 months ago

Cencora Transcript: 44th Annual J.P. Morgan Healthcare Conference


Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 12:00 PM EST - 7 months ago

Cencora Slides: 44th Annual J.P. Morgan Healthcare Conference


Cencora Earnings Call Transcript: Q4 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

Cencora Earnings Call Transcript: Q4 2025


Cencora Annual report: Q4 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

Cencora Annual report: Q4 2025


Cencora Earnings release: Q4 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

Cencora Earnings release: Q4 2025


Cencora Slides: Q4 2025

Nov 5, 2025, 8:30 AM EST - 9 months ago

Cencora Slides: Q4 2025


The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 10 months ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

MCK WFC


Cencora Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 11 months ago

Cencora Transcript: Baird Global Healthcare Conference 2025


Cencora Earnings Call Transcript: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q3 2025


Cencora Earnings release: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings release: Q3 2025


Cencora Quarterly report: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Quarterly report: Q3 2025


Cencora Slides: Q3 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Cencora Slides: Q3 2025


Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Third Quarter Results


Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 1 year ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors


Cencora Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings Call Transcript: Q2 2025


Cencora Quarterly report: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Quarterly report: Q2 2025


Cencora Earnings release: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Earnings release: Q2 2025


Cencora Slides: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Cencora Slides: Q2 2025


Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 1 year ago

Cencora Reports Fiscal 2025 Second Quarter Results


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 1 year ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM


Cencora Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings Call Transcript: Q1 2025


Cencora Quarterly report: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Quarterly report: Q1 2025


Cencora Earnings release: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Earnings release: Q1 2025


Cencora Slides: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Cencora Slides: Q1 2025


Cencora raises 2025 profit forecast on specialty drug demand

Feb 5, 2025, 7:23 AM EST - 1 year ago

Cencora raises 2025 profit forecast on specialty drug demand


27R
27R Aug. 4 at 3:29 PM
$COR Buckle up — earnings before the open tomorrow.
0 · Reply
JustinSilva985
JustinSilva985 Aug. 3 at 3:09 PM
$COR $DAL $BKR $O $F Cencora leads pharmaceutical distribution, Delta Air Lines benefits from travel demand, Baker Hughes expands energy technology, Realty Income generates dependable dividends, and Ford advances its EV and truck strategy.
0 · Reply
DonaldTillman163
DonaldTillman163 Aug. 3 at 2:43 PM
$COR $DAL $BKR $O $F Cencora leads pharmaceutical distribution, Delta Air Lines benefits from travel demand, Baker Hughes expands energy technology, Realty Income generates dependable dividends, and Ford advances its EV and truck strategy.
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 28 at 5:27 PM
$COR $ABC $HUM $OTLK https://www.nbcnews.com/id/wbna14785668
0 · Reply
Texastradinggirl
Texastradinggirl Jul. 27 at 8:02 PM
$OTLK Thoughts on this please..... Cencoran's Chairman of the Board placed an insider trade in June. (his own money) $COR He seems to be involved in taking this product to market. What do you think may be going on?
0 · Reply
CrazyChief
CrazyChief Jul. 25 at 2:54 PM
$OTLK Definitely know what you own!!! $COR
0 · Reply
CrazyChief
CrazyChief Jul. 24 at 11:43 PM
$OTLK Having the US FDA approval is Huge, sit back and enjoy the ride!! $COR is involved, many possibilities in our future!!
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 24 at 10:26 PM
$OTLK Congrats on #OTLK’s 1st FDA APPROVAL DAY! $ABC $COR $PILL In the USA, do you predict after initial orders, that reordering is frequently:
0 · Reply
CrazyChief
CrazyChief Jul. 24 at 7:25 PM
$OTLK $COR BIG THINGS WILL HAPPEN
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 24 at 6:32 PM
0 · Reply
DidYouReadThis
DidYouReadThis Jul. 24 at 5:07 PM
$OTLK $COR $ABC Good luck $OTLK 7/29/26 #PDUFA and with #AugustEarnings!
1 · Reply
OnlyFibs
OnlyFibs Jul. 7 at 3:56 AM
$COR is pushing higher toward $296.51 after delivering a solid Q2 fiscal 2026 print with revenue hitting $78.4B and raising full-year adjusted EPS guidance to $17.65-$17.90. Strategic contributions from the OneOncology integration are driving strong gross margin expansion in U.S. Healthcare Solutions. Discipline and key level defense remain our edge ahead of the upcoming Q3 earnings release on August 5. 🐂🎯 Bull Key Levels: Holding a firm base above $285.00 is vital to maintain upside momentum toward the $315.00 resistance pivot. 🐂🔥 Bear Key Levels: Slipping back under $268.00 exposes a structural retest of prior multi-month demand floors. 🐻⚠️ Take Profit Targets: $315.00 / $340.00. 💰💸#hovdid #COR #Cencora #Healthcare #Pharma #Trading
0 · Reply
SmartInsider
SmartInsider Jul. 2 at 4:33 AM
Cencora Inc - $COR on May 29th, 2026 Learn more: https://www.smartinsider.com/stock-of-the-week/cor-us-ranked-positive-on-may-29th-2026/ See disclaimer: https://www.smartinsider.com/disclaimer/
0 · Reply
DidYouReadThis
DidYouReadThis Jun. 23 at 7:11 PM
$OTLK does anyone remember if $MCK had been mentioned before? $COR isn’t a surprise. Any guesses on potential other channel #partners? Good luck $OTLK on PDUFA Wednesday 7/29/26!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 7:02 PM
$COR Current Stock Price: $279.51 Contracts to trade: $280.0 COR Jul 17 2026 Call Entry: $7.80 Exit: $14.16 ROI: 82% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Roxy123321
Roxy123321 Jun. 23 at 4:59 PM
$COR Will this go up or come down to where it was before?
0 · Reply
G101SPM
G101SPM Jun. 23 at 2:29 PM
#INSIDERS $COR Director bought 4,000 shares at $274.19 worth approximately $1.1 mln (transaction date 6/18). $LOVE President and one (1) Director bought 31,720 shares combined at $14.105 - $14.83 worth approximately $465K (transaction dates 6/18-6/22). $MSTR Chief Executive Officer bought 11,000 shares of Series A Perpetual Stretch Preferred Stock worth approximately $999K (transaction date 6/22). $JPM General Counsel sold 5,467 shares at $330.7337 worth approximately $1.8 mln (transaction date 6/22). $LWAY 10% owner sold 50,000 shares at $26.00 - $26.99 worth approximately $1.3 mln (transaction date 6/22).
0 · Reply
jontanaj
jontanaj Jun. 23 at 1:15 AM
$COR https://youtu.be/yipav-YwAsc?is=8OhThthkNnCK0ar5
0 · Reply
jhalimath61
jhalimath61 Jun. 22 at 10:54 PM
$COR 300 in August
1 · Reply
FilingTracker
FilingTracker Jun. 22 at 8:09 PM
$COR $1.1 million insider purchase: https://filingtracker.ai/filing/1140859/0001202358-26-000006
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 12 at 4:03 PM
0 · Reply
cynicaloptimist
cynicaloptimist Jun. 8 at 12:50 AM
$COR 👁
0 · Reply